03613.HK
Beijing Tong Ren Tang Chinese Medicine Company Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 5.97
+0.59%Year over year
Reported trailing growth
- Revenue
- +4.5%
- EBITDA
- +4.9%
- EBIT
- -3.8%
- EPS
- -5.9%
- Free cash flow
- +694.2%
- Operating cash flow
- +513.8%
Forward estimates
Based on analyst estimates
- Revenue
- -65.4%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.4%
- EBITDA
- -18.3%
- EBIT
- -16.5%
- Net income
- -15.0%
- EPS
- -15.2%
- Free cash flow
- +17.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026